Maloney votes for 21st Century Cures Act to make major investment in healthcare innovation

Jul 10, 2015
Press Release
Bill provides $8.75 billion for National Institutes of Health

WASHINGTON – Congresswoman Carolyn B. Maloney (D-NY) today voted to approve the 21st Century Cures Act. The bill delivers $8.75 billion in mandatory funding for the National Institutes of Health over the next 5 years to spur scientific innovation and discovery.

“Every dollar we invest in health research yields more than two dollars in economic return, yet funding for NIH has been cut repeatedly over the past few years because of across the board spending cuts,” said Maloney. “That’s why I was proud to support the 21st Century Cures Act, which will provide an additional $8.75 billion to NIH over five years. Investing in health research is critically important and this bill will go a long way toward finding cures and treatments to some of our most challenging diseases and health issues. I also expect that many of the health institutions that I’m proud  to represent will benefit from this increased investment in NIH because of their amazing research track records.”

The 21st Century Cures Act:

  • Provides $8.75 billion in mandatory funding for NIH over the next five years
  • Promotes the maintenance of the best biomedical workforce in the world, including increasing the diversity of the biomedical workforce
  • Modernizes clinical trials and supports inclusion of diverse populations in clinical research
  • Encourages the development of next generation treatments
  • Makes improvements to how FDA approves new drugs and devices
  • Provides FDA with Resources to Keep Pace with Innovation
  • Reduces Unnecessary Administrative Burdens on NIH and FDA